Business · 15/08/2001Updated: 10/17/2026 · 1 min read
FDA Withdraws Approval of EVSCO Pharmaceuticals' NADAs
Summary
The FDA is withdrawing approval of two new animal drug applications submitted by EVSCO Pharmaceuticals, an affiliate of IGI, Inc., due to the products no longer being manufactured or marketed.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →